Home › NDC Lookup › RxCUI directory › RxCUI 2572365

Varenicline 0.03 MG/ACTUAT Nasal Spray — RxCUI 2572365

RxNorm drug concept · Semantic clinical drug
RxCUI 2572365 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2572365
Official nameVarenicline 0.03 MG/ACTUAT Nasal Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asvarenicline 0.03 MG per 0.05 mL (as varenicline tartrate 0.05 MG per 0.05 mL) Nasal Spray
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)8,153 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Varenicline: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • They both contain varenicline, but they are completely different products used for completely different things. Chantix and the generic tablets are taken by mouth to help you quit...
  • What's the difference between Chantix (or the generic tablets) and Tyrvaya? Are they the same thing?
  • Nausea is the most common side effect, and it affects a real number of people, but the good news is it's usually mild to moderate and often improves as your body adjusts. Starting...
  • Nausea sounds rough — is it going to be bad the whole time I'm on the tablets?
📖 Read our full Varenicline guide →

🕸️ Concept Web — How Varenicline 0.03 MG/ACTUAT Nasal Spray Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Varenicline 0.03 MG/ACTUAT Nasal Spray RxCUI 2572365

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Varenicline 591622
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tyrvaya 2572366
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Varenicline Nasal Spray 2572364
    • Varenicline Inhalant Product 2572362
    • Varenicline Nasal Product 2572363
    • Varenicline Nasal Spray [Tyrvaya] 2572370
    • Tyrvaya Inhalant Product 2572368
    • Tyrvaya Nasal Product 2572369
    • Nasal Spray 126542
    • Inhalant Product 1151123
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Varenicline 0.03 MG/ACTUAT SCDC · 2572361
  • Varenicline Nasal Spray SCDF · 2572364
  • Varenicline Inhalant Product SCDG · 2572362
  • Varenicline Nasal Product SCDG · 2572363

Brand-Name Concepts

  • Varenicline 0.03 MG/ACTUAT Nasal Spray [Tyrvaya] SBD · 2572371
  • Varenicline 0.03 MG/ACTUAT [Tyrvaya] SBDC · 2572367
  • Varenicline Nasal Spray [Tyrvaya] SBDF · 2572370
  • Tyrvaya Inhalant Product SBDG · 2572368
  • Tyrvaya Nasal Product SBDG · 2572369
  • Tyrvaya BN · 2572366

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2572365 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
73521-0030-02 2 BOTTLE, PUMP in 1 CARTON (73521-030-02) / 4.2 mL in 1 BOT... Tyrvaya Oyster Point Pharma, Inc. 2021-10-20
73521-0030-90 1 BOTTLE, PUMP in 1 CARTON (73521-030-90) / 4.2 mL in 1 BOT... Tyrvaya Oyster Point Pharma, Inc. 2021-10-20
Observed labelers: Oyster Point Pharma, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$79.6369
Range $79.6369–$79.6369 · middle 50% $79.6369–$79.6369 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.